Comparable stake leader
T. Rowe Price Investment Management, Inc.
SEC ownership of Applied Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001697532.
Disclosed value leader
Shoshana Shendelman
Comparable rows
12/20
Latest evidence
29 Dec 2025
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
T. Rowe Price Investment Management, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
12 of 20
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
T. Rowe Price Investment Management, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
29 Dec 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001697532
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Applied Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
T. Rowe Price Investment ...
Disclosed value leader
Shoshana Shendelman
Comparable rows
12/20
Latest evidence
29 Dec 2025
13D/G
3/4/5
Lead comparable stake: 15%
8 rows are not safely comparable across share classes.
13D/G row: T. Rowe Price Investment Management, Inc.
Showing 1-8 of 20 holder rows.
Quick read
T. Rowe Price Investment Management, Inc. leads the comparable SEC ownership view at 15%.
12 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens T. Rowe Price Investment Management, Inc.'s linked filing trail.
Comparable ownership
Top 5
T. Rowe Price Investment Manageme...
15%
Alyeska Investment Group, L.P.
5.8%
ALEXANDRIA REAL ESTATE EQUITIES, ...
4.3%
Propel Bio Management, LLC
4.2%
Venrock Healthcare Capital Partne...
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 20 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. |
13D/G
|
15%
|
$12,946,856
21,403,300 shares
|
+$1,644,911 | 30 Sep 2025 |
| Alyeska Investment Group, L.P. |
13D/G
|
5.8%
|
$2,615,924
6,707,497 shares
|
$0 | 31 Dec 2024 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. |
3/4/5
13D/G
10%+ Owner
|
4.3%
from 13D/G
|
$24,825,526
7,355,077 shares
mixed-class rows
|
— | 04 Jun 2024 |
| Propel Bio Management, LLC |
13D/G
|
4.2%
|
$1,564,002
6,015,394 shares
|
$0 | 29 Dec 2025 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
4.1%
|
$2,171,407
5,567,709 shares
|
-$2,432,661 | 31 Mar 2025 |
| BlackRock, Inc. |
13D/G
|
3.7%
|
$1,003,183
5,219,475 shares
|
-$783,523 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
3.3%
|
$1,473,225
4,734,013 shares
|
-$359,492 | 30 Jun 2025 |
| Schonfeld Strategic Advisors LLC |
13D/G
|
3.3%
|
$1,823,678
4,676,097 shares
|
-$1,596,482 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$4,816.
Buys
$0
Insiders: 0
Sells
$4,816
Insiders: 1
Net
-$4,816
Shares: -43,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 43,000
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 43,000 | $0 | $4,816 | -$4,816 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to Applied Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Shoshana Shendelman
Net 12M change
-$4,816
Latest report
03 Feb 2026
Recent insider transactions for Applied Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Stacy J. Kanter | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -42,500 | 0 | 03 Feb 2026 | Direct | ||
| Stacy J. Kanter | APLT | Common Stock | Disposed to Issuer | -34.6% | -22,500 | 42,500 | 03 Feb 2026 | Direct | ||
| Stacy J. Kanter | APLT | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -263,690 | 0 | 03 Feb 2026 | Direct | ||
| Constantine Chinoporos | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -57,111 | 0 | 03 Feb 2026 | Direct | ||
| Constantine Chinoporos | APLT | Common Stock | Disposed to Issuer | -94.6% | -1,000,000 | 57,111 | 03 Feb 2026 | Direct | ||
| Leslie D. Funtleyder | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -152,959 | 0 | 03 Feb 2026 | Direct | ||
| Leslie D. Funtleyder | APLT | Common Stock | Disposed to Issuer | -94% | -2,375,000 | 152,959 | 03 Feb 2026 | Direct | ||
| Leslie D. Funtleyder | APLT | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -254,192 | 0 | 03 Feb 2026 | Direct | ||
| Evan Prescott Bailey | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -60,901 | 0 | 03 Feb 2026 | Direct | ||
| Evan Prescott Bailey | APLT | Common Stock | Disposed to Issuer | -95.3% | -1,235,915 | 60,901 | 03 Feb 2026 | Direct | ||
| Evan Prescott Bailey | APLT | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -24,414 | 0 | 03 Feb 2026 | Direct | ||
| Teena Lerner | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -82,922 | 0 | 03 Feb 2026 | Direct | ||
| Teena Lerner | APLT | Common Stock | Disposed to Issuer | -21.3% | -22,500 | 82,922 | 03 Feb 2026 | Direct | ||
| Teena Lerner | APLT | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -287,631 | 0 | 03 Feb 2026 | Direct | ||
| Corwin Dale Hooks | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -5,753 | 0 | 03 Feb 2026 | Direct | ||
| Corwin Dale Hooks | APLT | Common Stock | Disposed to Issuer | -99.3% | -862,500 | 5,753 | 03 Feb 2026 | Direct | ||
| Jay S. Skyler | APLT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -42,500 | 0 | 03 Feb 2026 | Direct | ||
| Jay S. Skyler | APLT | Common Stock | Disposed to Issuer | -34.6% | -22,500 | 42,500 | 03 Feb 2026 | Direct | ||
| Jay S. Skyler | APLT | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -263,690 | 0 | 03 Feb 2026 | Direct | ||
| Leslie D. Funtleyder | APLT | Common Stock | Award | 12.6% | 150,000 | 1,340,459 | 01 Jan 2026 | Direct | ||
| Constantine Chinoporos | APLT | Common Stock | Award | 70.6% | 437,500 | 1,057,111 | 19 Dec 2025 | Direct | ||
| Leslie D. Funtleyder | APLT | Common Stock | Award | 88.6% | 1,187,500 | 2,527,959 | 19 Dec 2025 | Direct | ||
| Evan Prescott Bailey | APLT | Common Stock | Award | 50.9% | 437,500 | 1,296,816 | 19 Dec 2025 | Direct | ||
| Corwin Dale Hooks | APLT | Common Stock | Award | 56.2% | 312,500 | 868,253 | 19 Dec 2025 | Direct | ||
| Stacy J. Kanter | APLT | Common Stock | Sale | -39.8% | $4,816 | $0.1120 | -43,000 | 65,000 | 16 Dec 2025 | Direct |
| Leslie D. Funtleyder | APLT | Common Stock | Award | 14.4% | 150,000 | 1,190,459 | 01 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.